Clin2
NCT04557995Possibly a fitRecruiting

Blood-filter treatment for chronic high-altitude sickness

Chronic Mountain Sickness

Part of Lungs & breathing clinical trials.

This trial studies “erythrocytapheresis,” a procedure that filters part of the blood, to improve symptoms of chronic mountain sickness caused by long-term living at high altitude. It may help people with high-altitude–related headaches, dizziness, shortness of breath, poor sleep, fatigue, and related signs.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
112 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You are at least 18 years old
  • You live at high altitude (at least 2,500 meters) continuously for at least 1 year, with no recent travel to low altitude in the last 3 months
  • Your blood test shows high hemoglobin (men ≥210 g/L, women ≥190 g/L) and you have mountain sickness symptoms or signs
  • Your chronic mountain sickness symptom score is high enough (total score ≥6)
  • You can sign consent (or a legal representative can)
  • You have not had similar high-altitude blood treatments or specific medicines in the last 6 months

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07639931Not yet recruiting
Treatment for severe altitude sickness

This trial tests new ways to diagnose and treat severe altitude sickness, which can cause fluid in the lungs or swelling in the brain. It aims to improve care for people who get very sick after climbing to high altitudes quickly.

Lhasa, Tibet
NCT07536477Recruiting
High-flow oxygen versus standard oxygen for altitude lung swelling

This trial tests whether high-flow oxygen (delivered through a special nasal tube) works better than standard oxygen therapy for a condition called high-altitude pulmonary edema (HAPE)—fluid buildup in the lungs caused by rapid ascent to high altitude. The study aims to see which approach helps patients breathe better and recover faster.

Xigazê, Tibet
NCT07562464Not yet recruiting· Phase 3
Blood pressure cuff treatment for high-altitude polycythemia

This study tests a treatment called remote ischemic conditioning (using a blood pressure cuff to briefly stop blood flow in your arm, which is thought to protect the body) to see if it can help people with high-altitude polycythemia, a condition where your body makes too many red blood cells because of the thin air at high altitudes.

NCT07562477Not yet recruiting· Phase 3
Blood pressure treatment for high-altitude residents

This study tests a non-drug treatment called remote ischemic conditioning to see if it can lower blood pressure in people with high blood pressure who live at high altitudes. The treatment involves briefly inflating and deflating a blood pressure cuff on the arm, which may help improve blood pressure control.

NCT07118462Recruiting· Phase 4
Acetazolamide, high altitude, and plasma volume study

This trial tests how acetazolamide affects your body's fluid levels at high altitude. It might help understand if the drug can prevent altitude sickness.

Bishkek
NCT05349630Not yet recruiting· Early Phase 1
Iron pills and exercise at high altitude

This study tests whether taking iron pills helps your heart work better and improves your exercise when you are at high altitude. You will participate in exercise tests and take iron or a placebo, to see if iron can protect your heart in low-oxygen conditions.

Aurora, Colorado

Hear when a new Chronic Mountain Sickness trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.